Lee L. Swanström (USA-France)
Jie He (China)
Michio Hongo (Japan)
< back to the Program at a glance
Monday, September 4
2:00 – 4:00 pm
Pneumatic dilation for achalasia and other motility disorders
An evolving role and treatment paradigm
Chairs: Joel E. Richter (USA) – Eduardo de Moura (Brazil)
Discussant: Patrick S. Yachimski (USA)
- History of pneumatic dilation for achalasia. Don O. Castell (USA)
- Currents techniques of pneumatic dilation-fluro vs endoscopy. Patrick S. Yachimski (USA)
- Predictive factors for good and back outcomes of pneumatic dilation in treating achalasia.
Valter N. Felix (Brazil)
- Randomized controlled trials of pneumatic dilation vs Botox and surgery (Heller, POEM).
Peter Bauerfeind (Switzerland)
- Post procedure follow-up after pneumatic dilation: role of high resolution manometry, timed barium swallow and/or FLIP. Johannes Lenglinger (Switzerland)
- Success of pneumatic dilation in treating other motility disorders: EGJ outflow obstruction and DES, Jackhammer esophagus. Joel E. Richter (USA)
- Efficacy of pneumatic dilation in achalasia in Chaga’s disease.
- Complications of pneumatic dilation: Type, frequency and treatment. Radu Tutuian (Switzerland)
- Is endoscopic dilation an adequate therapy after failure of surgical treatment? Eduardo de Moura (Brazil)
- Why not pneumatic dilation in all patients initially with achalasia? Eduardo de Moura (Brazil)
- Why would we ever need pneumatic dilation with treating achalasia with our new surgeries?
Jean-Louis Frossard (Switzerland)
- Is there a role for prolonged stent dilation compared to pneumatic dilatation? Erwin Rieder (Austria)
- Does pneumatic dilation adversely affect subsequent treatment of achalasia with laparoscopic Heller or POEM? Lee Swanström (USA)
- What really happens to all the patients we dilate year after year? Stephen J. Sontag (USA)